Skip to main content

Mounjaro News (Page 2)

Diabetes Drug Maker, Sues Over Compounded Versions of Mounjaro

WEDNESDAY, Sept. 20, 2023 – Another diabetes drug maker is taking legal action against businesses in several states, alleging that they’re “fraudulently claiming” that their compounded products are t...

Lawsuit Against Makers of Ozempic, Mounjaro Claim Meds Caused 'Stomach Paralysis'

THURSDAY, Aug. 3, 2023 – A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk for severe stomach...

Lawsuit Against Makers of Ozempic, Mounjaro Claim Meds Caused 'Stomach Paralysis'

THURSDAY, Aug. 3, 2023 – A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk of severe stomach...

American Diabetes Association, June 23-26

The annual meeting of the American Diabetes Association was held this year from June 23 to 26 in San Diego and attracted more than 15,000 participants from around the world, including clinicians,...

Risk of Suicidal Thoughts With Popular Weight-Loss Drugs Being Investigated by European Regulators

TUESDAY, July 11, 2023 – The European Medicines Agency is investigating concerns that popular weight-loss drugs like Ozempic and Saxenda may be linked to suicidal thoughts and thoughts of self-harm....

Diabetes Medications: Choosing Which Ones Are Best for You

WEDNESDAY, July 5, 2023 – You have been diagnosed with type 2 diabetes. What are your medication options? That depends on what type of diabetes you have and what risk factors you carry. In type 2...

ADA: Once-Weekly Tirzepatide Leads to Weight Loss in Patients With Obesity, T2D

TUESDAY, June 27, 2023 – Once-weekly tirzepatide provides substantial and clinically meaningful reductions in body weight in adults with obesity and type 2 diabetes, according to a study published...

Mounjaro, Orforglipron, and CagriSema Line Up to Challenge Ozempic, Wegovy for Weight Loss

MONDAY, June 26, 2023 – After drugmaker Novo Nordisk tweaked its diabetes drug Ozempic into Wegovy — a formulation expressly designed to help users shed pounds — sales of both drugs skyrocketed. Oth...

FDA Approves Mounjaro (tirzepatide) Injection for the Treatment of Adults with Type 2 Diabetes

INDIANAPOLIS, May 13, 2022 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) injection, Eli Lilly and Company's (NYSE: LLY) new once-weekly GIP...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Weight Loss (Obesity / Overweight), Diabetes, Type 2

Mounjaro patient information at Drugs.com